Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 09, 2024 10:44 ET | Source: Research and Markets

India Antimalarial Drugs Market Research 2024: Competitive Landscape, Key Trends, Forecast & Opportunities, 2020-2030

Dublin, Oct. 09, 2024 (GLOBE NEWSWIRE) -- The "India Antimalarial Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" report has been added to ResearchAndMarkets.com's...
November 23, 2023 10:13 ET | Source: Research and Markets

Global Artemisinin Combination Therapy Market (2022-2027): An Artemisinin-Based Combination of Multiple Medicines That Are Matched in Terms of Half-Life Might Be the Future of Malaria Treatment

Dublin, Nov. 23, 2023 (GLOBE NEWSWIRE) -- The "Global Artemisinin Combination Therapy Market (2022-2027) by Combination Therapy Type, and Geography, Competitive Analysis and the Impact of Covid-19...
February 17, 2023 06:48 ET | Source: Research and Markets

Global Global Antimalarial Drugs Market Research Report 2022: Increasing Prevalence of Malaria Coupled with Surge in Research for New Drugs to Propel Growth - Forecasts to 2028

Dublin, Feb. 17, 2023 (GLOBE NEWSWIRE) -- The "Global Antimalarial Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Drug Type, By Drug Class, By...
April 01, 2021 10:38 ET | Source: Manus Bio

Manus Bio Awarded Additional Funding to Support its Artemisinin Development Program

CAMBRIDGE, Mass., April 01, 2021 (GLOBE NEWSWIRE) -- Manus Bio Inc. (Manus Bio), a company which produces complex natural products through advanced fermentation, announced today that it has received...
September 14, 2020 07:00 ET | Source: Mateon Therapeutics, Inc.

MATEON’S GLOBAL STUDY FOR ARTEMISININ INTERVENTION AGAINST COVID-19 CLEARED FOR PATIENT ENROLLMENT IN INDIA.

AGOURA HILLS, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics “Mateon” (OTC.QB: MATN), a leading developer of TGF-β therapeutics for oncology and COVID-19, announced today that its...
August 04, 2020 07:00 ET | Source: Mateon Therapeutics, Inc.

MATEON THERAPEUTICS AND ABIOGENESIS TO INITIATE CLINICAL STUDY TO TEST ARTEMISININ AS A TREATMENT FOR COVID-19 IN INDIA

AGOURA HILLS, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics (OTCQB: MATN), a leading developer of TGF-β therapeutics, will be working together with Abiogenesis to initiate ARTI-19...
May 09, 2019 11:32 ET | Source: Manus Bio

Manus Bio Awarded Next Stage of Funding to Continue Development of a Novel Production Method for Artemisinin

CAMBRIDGE, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Manus Bio Inc. (Manus Bio), a company which produces complex natural products through advanced fermentation, announced today that it has received...
January 11, 2018 10:51 ET | Source: Manus Bio

Manus Bio Awarded Funding to Develop Novel Production Method for Artemisinin

CAMBRIDGE, Mass., Jan. 11, 2018 (GLOBE NEWSWIRE) -- Manus Bio Inc. (Manus Bio), a company which produces complex natural products through advanced fermentation, announced today that it has received...